Skip to main content
. 2013 Sep 30;16(3):254–265. doi: 10.4048/jbc.2013.16.3.254

Table 1.

Patients characteristics

graphic file with name jbc-16-254-i001.jpg

CT=computed tomography; MRI=magnetic resonance imaging; F=female; NA=not available; R-CHOP=rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; SMILE=dexamethasone, methotrexate, l-asparaginase, and etoposide; Hyper CAVD=hyperfractionated chemotherapy in small dose with cycloposphamide, vincristine, doxorubicin, and dexamethasone.